Key result
Incidental ARVC variants occur in ~14% of pediatric exomes without yielding clinical ARVC.
Why the study?
Pathologic mutations in ARVC-associated genes carry sudden death risk, making it critical to determine the diagnostic relevance of incidentally identified variants found on expanding clinical WES.
Do incidentally identified variants in ARVC-associated genes among children undergoing clinical whole exome sequencing represent pathogenic ARVC markers or healthy background population variation?
Cohort (n=7,066)
No
Do incidentally identified variants in ARVC-associated genes among children undergoing clinical whole exome sequencing represent pathogenic ARVC markers or healthy background population variation?
Incidentally discovered variants in ARVC-associated genes on pediatric whole exome sequencing closely mirror healthy population background variation rather than pathogenic hotspots and are unlikely to represent monogenic ARVC in the absence of clinical suspicion.
Answers are grounded in this paper and cite their sources.
Incidental ARVC variants in pediatric WES warrant no disease-specific evaluation absent clinical suspicion; supports reclassification as benign background variation in variant databases.
BACKGROUND: With expanding use of clinical whole exome sequencing (WES), genetic variants of uncertain significance are increasingly identified. As pathologic mutations in genes associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) carry a risk of sudden death, determining the diagnostic relevance of incidentally identified variants associated with these genes is critical. METHODS: WES variants from a large, predominantly pediatric cohort (N = 7,066 probands) were obtained for nine ARVC-associated genes (Baylor Miraca). For comparison, a control cohort was derived from the gnomAD database and an ARVC case cohort (N = 1,379 probands) was established from ARVC cases in the literature. Topologic mapping was performed and signal-to-noise analysis was conducted normalizing WES, or case variants, against control variant frequencies. Retrospective chart review was performed of WES cases evaluated clinically (Texas Children's Hospital). RESULTS: Incidentally identified variants occurred in 14% of WES referrals and localized to genes which were rare among ARVC cases yet similar to controls. Amino acid-level signal-to-noise analysis of cases demonstrated "pathologic hotspots" localizing to critical domains of PKP2 and DSG2 while WES variants did not. PKP2 ARM7 and ARM8 domains and DSG2 N-terminal cadherin-repeat domains demonstrated high pathogenicity while normalized WES variant frequency was low. Review of clinical data available on WES referrals demonstrated none with evidence of ARVC among variant-positive individuals. CONCLUSIONS: Incidentally identified variants are common among pediatric WES testing with gene frequencies similar to "background" variants. Incidentally identified variants are unlikely to be pathologic.
No takes yet. Share an insight, caveat, or question.
Headrick et al. (2019) conducted a cohort in Arrhythmogenic right ventricular cardiomyopathy (ARVC)-associated genetic variants (n=7,066). Incidentally identified rare variants in nine ARVC-associated genes on whole exome sequencing vs. gnomAD population controls (N=138,632) and literature ARVC cases (N=1,379) was evaluated on Frequency of rare variants in nine ARVC-associated genes and clinical evidence of ARVC (95% CI 13.6-15.2). Incidentally identified ARVC-associated variants occurred in 14.4% of pediatric WES referrals, localized similarly to healthy controls, and resulted in 0% clinical ARVC.
Synapse has enriched 10 related papers. Consider them for comparative context: